These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 32195031)
1. The HIPPO pathway in gynecological malignancies. Wang D; He J; Dong J; Meyer TF; Xu T Am J Cancer Res; 2020; 10(2):610-629. PubMed ID: 32195031 [TBL] [Abstract][Full Text] [Related]
2. Hippo Signaling in Cancer: Lessons From Snigdha K; Gangwani KS; Lapalikar GV; Singh A; Kango-Singh M Front Cell Dev Biol; 2019; 7():85. PubMed ID: 31231648 [TBL] [Abstract][Full Text] [Related]
3. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis. Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS Front Oncol; 2019; 9():60. PubMed ID: 30805310 [TBL] [Abstract][Full Text] [Related]
4. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy. Juan WC; Hong W Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805 [TBL] [Abstract][Full Text] [Related]
5. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective. Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912 [TBL] [Abstract][Full Text] [Related]
6. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis. Boopathy GTK; Hong W Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911 [TBL] [Abstract][Full Text] [Related]
7. The Hippo signaling pathway in liver regeneration and tumorigenesis. Hong L; Cai Y; Jiang M; Zhou D; Chen L Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204 [TBL] [Abstract][Full Text] [Related]
8. YAP/TAZ: a promising target for squamous cell carcinoma treatment. Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073 [TBL] [Abstract][Full Text] [Related]
9. The regulation and function of YAP transcription co-activator. Zhu C; Li L; Zhao B Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920 [TBL] [Abstract][Full Text] [Related]
10. The role of the Hippo pathway in human disease and tumorigenesis. Barron DA; Kagey JD Clin Transl Med; 2014; 3():25. PubMed ID: 25097728 [TBL] [Abstract][Full Text] [Related]
11. Hippo and rassf1a Pathways: A Growing Affair. Fausti F; Di Agostino S; Sacconi A; Strano S; Blandino G Mol Biol Int; 2012; 2012():307628. PubMed ID: 22830020 [TBL] [Abstract][Full Text] [Related]
12. Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside. Liu X; Wang Y; Chen B; Chan WN; Mui CW; Cheung AHK; Zhang J; Wong KY; Yu J; Kang W; To KF Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289774 [TBL] [Abstract][Full Text] [Related]
13. Hippo pathway - brief overview of its relevance in cancer. Zygulska AL; Krzemieniecki K; Pierzchalski P J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of the mammalian Hippo signaling pathway. Ji XY; Zhong G; Zhao B Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470 [TBL] [Abstract][Full Text] [Related]
15. The Hippo Pathway: Biology and Pathophysiology. Ma S; Meng Z; Chen R; Guan KL Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373 [TBL] [Abstract][Full Text] [Related]
16. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Zhao B; Lei QY; Guan KL Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139 [TBL] [Abstract][Full Text] [Related]
17. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Varelas X Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453 [TBL] [Abstract][Full Text] [Related]
18. Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis. Azad T; Rezaei R; Surendran A; Singaravelu R; Boulton S; Dave J; Bell JC; Ilkow CS Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722184 [TBL] [Abstract][Full Text] [Related]
19. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas. Deel MD; Li JJ; Crose LE; Linardic CM Front Oncol; 2015; 5():190. PubMed ID: 26389076 [TBL] [Abstract][Full Text] [Related]
20. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms. Dobrokhotov O; Samsonov M; Sokabe M; Hirata H Clin Transl Med; 2018 Aug; 7(1):23. PubMed ID: 30101371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]